Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00946569 · ClinicalTrials.gov registry record · Phase 2

A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma

A Phase 2 study of Asthma, sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C..

Completed
Registry status
Phase 2
Development phase
116
Enrollment target
20
Study locations

NCT00946569 is a Phase 2 study of Asthma that has completed, run by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.. The registered enrollment target is 116 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (93% lower). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00946569, a Phase 2 study of Asthma, has completed, sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C..

COMPLETED
Registry status
Phase 2
Development phase
116 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to evaluate the safety and effectiveness of once daily oral administration of JNJ-39758979 in the treatment of adults (18 to 65 years of age) with persistent asthma.

Conditions Studied

Asthma

Interventions

  • DRUG Placebo
  • DRUG JNJ39758979

Study Locations (20)

California

  • - Cypress
  • - Los Angeles
  • - San Diego

Ontario

  • - Niagara Falls
  • - Ottawa
  • - Toronto

Oregon

  • - Medford
  • - Portland

Texas

  • - Dallas
  • - Waco

Arizona

  • - Scottsdale

Illinois

  • - Normal

Massachusetts

  • - North Dartmouth

Nebraska

  • - Papillion

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2009-08
Est. Completion 2010-09
Phase Phase 2

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

102 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00946569

The ClinicalTrials.gov registry entry for NCT00946569 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (93% lower). The listed sponsor is Johnson & Johnson Pharmaceutical Research & Development, L.L.C., which has 102 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00946569 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Ontario, Oregon.

Frequently Asked Questions

What is clinical trial NCT00946569 about?

NCT00946569 is a clinical study titled "A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma". The purpose of this study is to evaluate the safety and effectiveness of once daily oral administration of JNJ-39758979 in the treatment of adults (18 to 65 years of age) with persistent asthma.

What is the current status of trial NCT00946569?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 116 participants. The study started on 2009-08. Estimated completion is 2010-09.

What conditions does trial NCT00946569 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT00946569?

The interventions under investigation include: Placebo (DRUG), JNJ39758979 (DRUG).

Who is sponsoring clinical trial NCT00946569?

This trial is sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C., which has 102 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00946569 being conducted?

This trial has 20 study locations across Arizona, California, Illinois, Massachusetts, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.